Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries.
Kamusheva M, Manova M, Savova AT, Petrova GI, Mitov K, Harsányi A, Kaló Z, Márky K, Kawalec P, Angelovska B, Lakić D, Tesar T, Draganic P, Geitona M, Hatzikou M, Paveliu MS, Männik A. Kamusheva M, et al. Among authors: draganic p. Front Pharmacol. 2018 Jul 20;9:795. doi: 10.3389/fphar.2018.00795. eCollection 2018. Front Pharmacol. 2018. PMID: 30079023 Free PMC article.
Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries.
Kawalec P, Stawowczyk E, Tesar T, Skoupa J, Turcu-Stiolica A, Dimitrova M, Petrova GI, Rugaja Z, Männik A, Harsanyi A, Draganic P. Kawalec P, et al. Among authors: draganic p. Front Pharmacol. 2017 Jun 8;8:288. doi: 10.3389/fphar.2017.00288. eCollection 2017. Front Pharmacol. 2017. PMID: 28642700 Free PMC article.
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.
Kawalec P, Tesar T, Vostalova L, Draganic P, Manova M, Savova A, Petrova G, Rugaja Z, Männik A, Sowada C, Stawowczyk E, Harsanyi A, Inotai A, Turcu-Stiolica A, Gulbinovič J, Pilc A. Kawalec P, et al. Among authors: draganic p. Front Pharmacol. 2017 Dec 18;8:892. doi: 10.3389/fphar.2017.00892. eCollection 2017. Front Pharmacol. 2017. PMID: 29326583 Free PMC article.
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries.
Malinowski KP, Kawalec P, Trąbka W, Czech M, Petrova G, Manova M, Savova A, Draganić P, Vostalová L, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Malinowski KP, et al. Among authors: draganic p. Front Pharmacol. 2019 May 8;10:487. doi: 10.3389/fphar.2019.00487. eCollection 2019. Front Pharmacol. 2019. PMID: 31139080 Free PMC article.
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe.
Malinowski KP, Kawalec P, Trąbka W, Sowada C, Petrova G, Manova M, Savova A, Draganić P, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Malinowski KP, et al. Among authors: draganic p. Orphanet J Rare Dis. 2020 Oct 8;15(1):277. doi: 10.1186/s13023-020-01556-9. Orphanet J Rare Dis. 2020. PMID: 33032634 Free PMC article.
Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries.
Jakubowski S, Kawalec P, Holko P, Kowalska-Bobko I, Kamusheva M, Petrova G, Draganić P, Fuksa L, Männik A, Ispán F, Briedis V, Bianchi I, Paveliu MS, Tesar T. Jakubowski S, et al. Among authors: draganic p. Front Pharmacol. 2024 Mar 8;15:1369178. doi: 10.3389/fphar.2024.1369178. eCollection 2024. Front Pharmacol. 2024. PMID: 38523639 Free PMC article.
16 results